PanGenex Corporation: PGCX; A Nutraceutical Giant In the Making

New York, New York – November 30, 2009 - PanGenex is a publicly traded corporation (PINK SHEETS: PGCX) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products.

PanGenex Corporation’s primary market is the Nutraceuticals market.  Nutraceutical refers to foods or extracts thereof claimed to have a medicinal effect on human health.

PanGenex develops, manufactures and distributes nutraceutical and dietary supplements, Over-the Counter (OTC) topical drugs and personal care products focused on cardiovascular health and wellness. PanGenex's patented, trademarked and proprietary formulations address the root cause of some the world's most prevalent diseases affecting aging populations. Many products contain the purest grade of nutraceuticals available anywhere without a prescription. PanGenex voluntarily submits its products without incidence to the US Food and Drug Administration.

PanGenex’s products are manufactured at state-of-the-art, Certified Good Manufacturing Practices (cGMP)-compliant facilities. Products are sold direct to health care practitioners in the U.S., Canada, South America and Europe, high-end retail and direct-to-consumer over the Internet.

From a trading overview, PGCX is currently an undervalued stock, in a market with such giants as General Mills (GIS), Martek Biosciences (MATK), Nutraceutical International Corporation (NUTR), all $2 and higher stocks.  PGCX is at present moment in a very lucrative market with a strong product offering and a great research program which is leading to various new patents and products.

Some Investment Highlights on PGCX include:

• Explosive Market Demand – Worldwide sales of nutraceuticals are expected to increase at a compound annual growth rate of 7.4% to $176.7 Billion in 2013.*
• Scientifically formulated products are backed by a decade of research and development
• Widespread applications address the root cause of over 50% of the diseases listed as the nation's leading causes of death.
• 78 Million Aging “Baby Boomers” - More than 70% of those aged 55 and over take a daily supplement
• Patent-pending product lines target both the nutraceutical and pharmaceutical industries
• Partnerships with top medical doctors and life science professionals
• Strong physician relationships and referral network to propel growth
• Global distribution channels including North and South America, and Europe
• Renowned cardiologists on the Board of Directors and Scientific Advisory Board

PanGenex Corporation (PGCX) is in our belief a stock that has a potential for a 300% increase in share value and based on this morning’s volume and price fluctuation, it is on its way to an explosive breakout.  Expect the stock to reach its first breakout point, where it will amass stronger volume and begin taking on much stronger bullish tendencies.

As always, we encourage you to do your homework and effect your own research.

For a comprehensive overview of PanGenex Corporation, Please Click on the following link

PANGENEX CORPORATE OVERVIEW

ABOUT XPLOSIVESTOCKS.COM

XplosiveStocks.com is a leading stock website that provides free daily alerts on stocks that are moving up. Xplosivestocks.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contacts us at info@xplosivestocks.com.

XplosiveStocks.com is an independent electronic publication that provides information on selected publicly traded companies. XplosiveStocks.com is not a registered investment advisor or broker-dealer. XplosiveStocks.com's affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and XplosiveStocks.com undertakes no obligation to update such statements.

CONTACT: XplosiveStocks.com e-mail: info@xplosivestocks.com WWW: http://www.xplosivestocks.com